Is arterial stiffness better than blood pressure in predicting cardiovascular risk?

Current Cardiovascular Risk Reports

Volumn 2, Issue 2, 2008, Pages 133-140

  Hashimoto, Junichiro ^b   O'Rourke, Michael F ^a  

^a ST VINCENT'S CLINIC   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56549129861     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-008-0025-0     Document Type: Article

References (69)

1. Laurent S, Cockcroft J, van Bortel L, et al.: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27: 2588-2605.
2. Blacher J, Guerin AP, Pannier B, et al.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99: 2434-2439.
3. Guerin AP, Blacher J, Pannier B, et al.: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001, 103: 987-992.
4. Laurent S, Boutouyrie P, Asmar R, et al.: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37: 1236-1241.
5. Meaume S, Benetos S, Henry OF, et al.: Aortic pulse wave velocity predicts cardiovascular mortality in subjects & 70 years of age. Arterioscler Thromb Vasc Biol 2001, 21: 2046-2050.
6. Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39: 10-15.
7. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al.: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005, 111: 3384-3390.
8. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al.: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006, 113: 657-663.
9. Willum Hansen T, Staessen JA, Torp-Pedersen C, et al.: Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006, 113: 664-670.
10. Pannier B, Guerin AP, Marchais SJ, et al.: Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 2005, 45: 592-596.
11. Kullo IJ, Bielak LF, Turner ST, et al.: Aortic pulse wave velocity is associated with the presence and quality of coronary artery calcium: a community-based study. Hypertension 2006, 47: 174-179.
12. London GM, Guerin AP, Marchais SJ, et al.: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996, 50: 600-608.
13. Briet M, Bozec E, Laurent S, et al.: Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2006, 69: 350-357.
14. Schillaci G, Pirro M, Mannarino MR, et al.: Relationship between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension 2006, 48: 616-621.
15. Smith A, Karalliedde J, De Angelis L, et al.: Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol 2005, 16: 1069-1075.
16. Hanon O, Haulon S, Lenoir H, et al.: Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke 2005, 36: 2193-2197.
17. O'Rourke MF, Hashimoto J: Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007, 50: 1-13.
18. Mitchell GF, Vita JA, Larson MG, et al.: Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 2005, 112: 3722-3728.
19. Yasmin, McEniery CM, Wallace S, et al.: C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24: 969-974.
20. Yasmin, Wallace S, McEniery CM, et al.: Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25: 372-378.
21. Mahmud A, Feely J: Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005, 46: 1118-1122.
22. Vlachopoulos C, Dima I, Azanaouridis K, et al.: Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005, 112: 2193-2200.
23. Hashimoto J, O'Rourke MF: C-reactive protein and cardiovascular disease: are we looking in the right direction?J Hypertens 2006, 24: 2115.
24. Levy D, Hwang SJ, Kayalar A, et al.: Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness. The Framingham Heart Study. Circulation 2007, 115: 3079-3085.
25. London GM, Blacher J, Pannier B, et al.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38: 434-438.
26. Weber T, Auer J, O'Rourke MF, et al.: Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005, 26: 2657-2663.
27. Chirinos JA, Zambrano JP, Chakko S, et al.: Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005, 45: 980-985.
28. Dart AM, Gatzka CD, Kingwell BA, et al.: Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female subjects. Hypertension 2006, 47: 785-790.
29. Waddell TK, Dart AM, Medley TL, et al.: Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension 2001, 38: 927-931.
30. O'Rourke MF, Nichols WW, Safar ME: Brachial and central artery pressure. Hypertension 2006, 48: e1.
31. Hashimoto J, Imai Y, O'Rourke MF: Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens 2007, 20: 378-384.
32. Hashimoto J, Imai Y, O'Rourke MF: Monitoring of antihypertensive therapy for reduction in left ventricular mass. Am J Hypertens 2007, 20: 1229-1233.
33. Saba PS, Roman MJ, Pini R, et al.: Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993, 22: 1873-1880.
34. Marchais SJ, Guerin AP, Pannier BM, et al.: Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 1993, 22: 876-883.
35. Hashimoto J, Watabe D, Hatanaka R, et al.: Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy. Am J Hypertens 2006, 19: 27-32.
36. Weber T, Auer J, O'Rourke MF, et al.: Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004, 109: 184-189.
37. Covic A, Haydar AA, Bhamra-Ariza P, et al.: Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005, 18: 388-396.
38. Tsioufis C, Tzioumis C, Marinakis N, et al.: Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension. Nephron Clinical Pract 2003, 93: c106-c111.
39. Li Y, Wang JG, Dolan E, et al.: Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 2006, 47: 359-364.
40. Dolan E, Thijs L, Li Y, et al.: Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006, 47: 365-370.
41. Hansen TW, Staessen JA, Torp-Pedersen C, et al.: Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 2006, 24: 2247-2253.
42. Leoncini G, Ratto E, Viazzi F, et al.: Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 2006, 48: 397-403.
43. Ratto E, Leoncini G, Viazzi F, et al.: Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens 2006, 24: 2033-2038.
44. Schillaci G, Parati G, Pirro M, et al.: Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension 2007, 49: 986-991.
45. Schillaci G, Pucci G, Pierro M, et al.: Response to interstudy variability of ambulatory arterial stiffness index. Hypertension 2007, 50: e66.
46. Laurent S: Surrogate measures of arterial stiffness. Do they have additive predictive value or are they only surrogates of a surrogate?Hypertension 2006, 47: 325-326.
47. Boutouyrie P, Bussy C, Lacolley P, et al.: Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999, 100: 1387-1393.
48. De Luca N, Asmar RG, London GM, et al.: Selective reduction of cardiac mass on low-dose combination perindopril/ indapamide in hypertensive subjects. J Hypertens 2004, 22: 1623-1630.
49. Williams B, Lacy PS, Thom SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113: 1213-1225.
50. Safar ME, Blacher J, Pannier B, et al.: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39: 735-738.
51. Roman MJ, Devereux RB, Kizer JR, et al.: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure. Hypertension 2007, 50: 197-203.
52. Shoji T, Emoto M, Shinohara K, et al.: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001, 12: 2117-2124.
53. Cruickshank K, Riste L, Anderson SG, et al.: Aortic pulsewave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?Circulation 2002, 106: 2085-2090.
54. Ueda H, Hayashi T, Tsumura K, et al.: The timing of the reflected wave in the ascending aortic pressure predicts restenosis after coronary stent placement. Hypertens Res 2004, 27: 535-540.
55. Boutouyrie P, Bussy C, Hayoz D, et al.: Boutouyrie Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 2000, 101: 2601-2606.
56. Kelly R, Daley J, Avolio A, O'Rourke M: Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension. Hypertension 1989, 14: 14-21.
57. London GM, Pannier B, Guerin AP, et al.: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994, 90: 2786-2796.
58. Chen CH, Ting CT, Lin SJ, et al.: Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995, 25: 1034-1041.
59. Bénétos A, Laflèche A, Asmar R, et al.: Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension. J Hum Hypertens 1996, 10: 77-82.
60. Pannier BM, Guerin AP, Marchais SJ, London GM: Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol 2001, 28: 1074-1077.
61. Mahmud A, Feely J: Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 2002, 15(4 Pt 1): 321-325.
62. Klingbeil AU, John S, Schneider MP, et al.: AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens 2002, 20: 2423-2428.
63. Mahmud A, Feely J: Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002, 15: 1092-1095.
64. Morgan T, Lauri J, Bertram D, Anderson A: Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004, 17: 118-123.
65. London GM, Asmar RG, O'Rourke MF, et al.: Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004, 43: 92-99.
66. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF: Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?J Hypertens 2005, 23: 551-556. [Published erratum appears in J Hypertens 2005, 23: 903-904.].
67. Dhakam Z, McEniery CM, Yasmin, et al.: Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006, 19: 214-219.
68. Jiang XJ, O'Rourke MF, Zhang YQ, et al.: Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens 2007, 25: 1095-1099.
69. Dart AM, Cameron JD, Gatzka CD, et al.: Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007, 49: 1242-1247.